manfredi bruno sequi

Dr. manfredi bruno sequi

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 April 2023 in Prostate Cancer and Prostatic Diseases
Verified
Journal Article
Closed access
PDF file
AFAndrea Fuschi
Andrea Fuschi
Antonio Luigi PastoreAntonio Luigi Pastore
Antonio Luigi Pastore
YSYazan Al Salhi
Yazan Al Salhi
AMAlessia Martoccia
Alessia Martoccia
CNCosimo De Nunzio
Cosimo De Nunzio
ACAntonio Carbone
Antonio Carbone

Verified
Journal Article
Open access
PDF file
YSYazan Al Salhi
Yazan Al Salhi
MSmanfredi bruno sequi
manfredi bruno sequi
FVFabio Maria Valenzi
Fabio Maria Valenzi
AFAndrea Fuschi
Andrea Fuschi
AMAlessia Martoccia
Alessia Martoccia
CNCosimo De Nunzio
Cosimo De Nunzio
Cancer stem cells (CSCs) are a small and elusive subpopulation of self-renewing cancer cells with the remarkable ability to initiate, propagate, and spread malignant disease. In the past years, several authors have focused on the possible role of CSCs in PCa development and progression. PCa CSCs typically originate from a luminal prostate cell. Three main pathways are involved in the CSC development, including the Wnt, Sonic Hedgehog, and Notch signaling pathways. Studies have observed an important role for epithelial mesenchymal transition in this process as well as for some specific miRNA. These studies led to the development of studies targeting these specific pathways to improve the management of PCa development and progression. CSCs in prostate cancer represent an actual and promising field of research.

27 December 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
AFAndrea Fuschi
Andrea Fuschi
YSYazan Al Salhi
Yazan Al Salhi
MSmanfredi bruno sequi
manfredi bruno sequi
GVGennaro Velotti
Gennaro Velotti
AMAlessia Martoccia
Alessia Martoccia
Antonio Luigi PastoreAntonio Luigi Pastore
Antonio Luigi Pastore
Background: Diversion after radical cystectomy (RC) is crucial when considering elderly subjects. Data on the quality of life (QoL) impact with different diversions is scarce. This study aims to compare complications and QoL in patients aged > 75 y.o., who underwent minimally invasive (MI) RC with Bricker intracorporeal urinary derivation and single stoma ureterocutaneostomy. Methods: We conducted a retrospective analysis of elderly patients who underwent MIRC and intracorporeal diversion. The 78 subjects were divided into two groups: group A, ileal conduit, and group B, single stoma ureterocutaneostomy. We evaluated the bowel’s recovery time and complications rate. We investigated QoL 3 and 6 months after surgery using the Stoma-QoL questionnaire. Results: Mean age was 77.2 in group A and 82.4 in group B. The mean ASA score and Charlson Comorbidity index were comparable between the two groups. Rates of complications were 57.6% and 37.4% in groups A and B, respectively. The mean postoperative Stoma-QoL score 3 months after surgery was 52.2 and 52.4 in groups A and B, respectively. At 6 months of follow-up the Stoma QoL mean score was 63.4, showing homogeneity between the groups. Conclusion: MIRC with single stoma ureterocutaneostomy represents an alternative to ileal conduit, with comparable QoL and ostomy management 6 months after surgery, reporting fewer complications.

1 January 2025 in Cancers
Verified
Journal Article
Open access
PDF file
CICarlo Introini
Carlo Introini
MSmanfredi bruno sequi
manfredi bruno sequi
MEMarco Ennas
Marco Ennas
ABAndrea Benelli
Andrea Benelli
GGGiovanni Guano
Giovanni Guano
ACAntonio Carbone
Antonio Carbone
Background/Objectives: Radical cystectomy (RC) is the standard treatment for muscle-invasive and high-risk non-muscle-invasive bladder cancer, but it often results in significant functional impairments, including sexual and urinary dysfunction, adversely affecting quality of life (QoL). Sexual-sparing robotic-assisted radical cystectomy (RARC) has been introduced to mitigate these effects. This review evaluates the oncological and functional outcomes of sexual-sparing RARC in male and female patients. Methods: A systematic literature search identified 15 studies including 793 patients who underwent sexual-sparing RARC using techniques such as nerve-sparing, capsule-sparing, and pelvic organ-preserving approaches. Data on oncological and functional outcomes were analyzed. Results: Sexual-sparing RARC achieves oncological outcomes comparable to open RC, with negative surgical margin (NSM) rates exceeding 95% in most studies. RFS and CSS rates were robust, often surpassing 85% at intermediate follow-ups. Functional outcomes were also favorable, with continence rates exceeding 90% and erectile function recovery surpassing 70% in well-selected male patients. Female patients undergoing pelvic organ-preserving techniques demonstrated improved continence, preserved sexual function, and enhanced QoL. Patient selection emerged as critical, favoring those with organ-confined disease and good baseline function. Conclusions: Sexual-sparing RARC offers a promising balance between oncological control and functional preservation, making it an effective option for selected patients. Further research is needed to refine techniques and establish standardized protocols for broader adoption.

12 April 2025 in Urolithiasis
Verified
Journal Article
Closed access
PDF file
FDFederico Dotta
Federico Dotta
MSmanfredi bruno sequi
manfredi bruno sequi
DGDamiano Graziani
Damiano Graziani
MTMattia Tosi
Mattia Tosi
ABAndrea Benelli
Andrea Benelli
CICarlo Introini
Carlo Introini

30 May 2025 in Cancers
Verified
Journal Article
Open access
PDF file
AFAndrea Fuschi
Andrea Fuschi
MSmanfredi bruno sequi
manfredi bruno sequi
YSYazan Al Salhi
Yazan Al Salhi
PSPaolo Pietro Suraci
Paolo Pietro Suraci
FVFabio Maria Valenzi
Fabio Maria Valenzi
Antonio Luigi PastoreAntonio Luigi Pastore
Antonio Luigi Pastore
Background: Cold dissection (CD) during nerve-sparing robot-assisted radical prostatectomy (nsRARP) in patients with prostate cancer has been proposed to improve functional outcomes by reducing the thermal damage to neurovascular bundles (NVBs). This study compares the impact of CD versus thermal dissection (TD) on postoperative early continence and erectile function recovery. Methods: A prospective comparative analysis was conducted on patients undergoing nsRARP, comparing CD and TD techniques. Continence was assessed at 15, 30, and 90 days, while erectile function was evaluated at 30, 90, and 180 days using IIEF-5 scores. Logistic and linear regression analyses were performed to identify predictors of functional recovery. Results: CD significantly improved early continence at 15 and 30 days (p < 0.05), although the difference diminished by 90 days. Erectile function recovery was consistently higher in the CD group at all time points (p < 0.01). Age negatively impacted continence and erectile function recovery, while preoperative IIEF-5 scores were strong predictors of erectile function. Prostate volume, BMI, and metabolic syndrome showed no significant influence on outcomes. Conclusions: CD enhances early continence and erectile function recovery following nsRARP by preserving NVBs and minimizing thermal damage. This technique offers a valuable approach to improving patient functional outcomes. Further studies are required to validate its long-term benefits.